LLT-1 specific mAbs (CNRS)

N/A

Report date: 2025/03/20 15:41:34

Base Information

Drug NameLLT-1 specific mAbs (CNRS)
Drug Alias Namelectin-like transcript-1 specific mAbs (CNRS)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-Type Lectin Domain Family 2 Member D inhibitorsKiller cell lectin-like receptor subfamily B member 1 inhibitors
TargetsKiller cell lectin-like receptor subfamily B member 1C-Type Lectin Domain Family 2 Member D
Therapy Area/IndicationsInflammationAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesCNRS InnovationCentre National De La Recherche Scientifique (Cnrs)
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A